SUPPLEMENTAL INFORMATION - Impact of Systemic Therapies in Metastatic Melanoma of Unknown Primary: A study from MELBASE, a French Multicentric Prospective Cohort

Published: 2 September 2022| Version 1 | DOI: 10.17632/6vndghdrtg.1
Contributors:
Perrine ROUSSET, Henri Montaudié

Description

Supplemental material for Manuscript: Impact of Systemic Therapies in Metastatic Melanoma of Unknown Primary: A study from MELBASE, a French Multicentric Prospective Cohort

Files

Categories

Supplementation

Licence